Clinical Trial Update: Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial [Phase 4]

View source ↗

Summary

A phase 4 multicenter trial studying peripheral histamine 1 receptor blockade for irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: KU Leuven | Conditions: Irritable Bowel Syndrome (IBS) | Phase 4 | Status: COMPLETED